SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001019056-16-001432
Filing Date
2016-08-02
Accepted
2016-08-02 20:41:48
Documents
2
Period of Report
2016-07-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT lamothe_3.html 3  
1 OWNERSHIP DOCUMENT lamothe_3.xml 3 1611
2 EXHIBIT 24 ex_24.htm EX-24 5649
  Complete submission text file 0001019056-16-001432.txt   8624
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Issuer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121
Business Address
Lamothe Jeffrey G. (Reporting) CIK: 0001679967 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37746 | Film No.: 161802041